Skip to content

Author

Makoto Tahara

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

Patients with de novo metastatic nasopharyngeal carcinoma were historically deemed incurable and treated with palliative intent. Emergence of potent systemic therapy in combination with local treatment for both locoregional and metastatic diseases has enabled long-term survival in some patients. This international guid...

Qiao-Juan Guo, Qin Liu, P. Bossi et al. · 0 citations
Oct 2026

Association between tumor volume reduction and treatment outcomes in nasopharyngeal carcinoma treated with PCE-based induction chemotherapy and concurrent chemoradiotherapy.

VRR was associated with PFS, suggesting that tumor shrinkage following IC-PCE may serve as a prognostic marker in patients with locoregional advanced nasopharyngeal carcinoma.

Ya Guo, Satoshi Saito, K. Makita et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.